Abstract
Objective To evaluate the treatment of patients with giant cell tumors of bone treated from
2009 to 2019 in a philanthropic hospital, as well as to try and determine the regional
clinical and epidemiological profile, aiming to enrich the Brazilian data set and
compare our findings with those of the literature.
Methods An analytical, observational, and cross-sectional study with retrospective data collection
and a quantitative approach, analyzing medical records of patients with giant cell
tumors treated at a philanthropic hospital from 2009 to 2019.
Results We evaluated 49 medical records; 55.1% of the patients were women, 53.1% were aged
between 20 and 40 years, 69.4% of the cases were Campanacci grade III, and 30.6% affected
the proximal end of the tibia. The rate of pathological fractures secondary to the
tumor and pulmonary metastasis was low. More than 69% of the patients underwent intralesional
surgery. Recurrence occurred in 16.3% of the cases.
Conclusion The criteria used for the diagnosis, classification, and treatment at our service
followed the standards established by the literature, and they can guide further research
and improve local prognosis in the future.
Keywords
giant cell tumors/diagnosis - giant cell tumors/classification - bone neoplasms
